Lehnert T, Herfarth C
Department of Surgery, University of Heidelberg, Germany.
Ann Surg. 1993 Apr;217(4):338-46. doi: 10.1097/00000658-199304000-00005.
This study identified risk factors of surgical treatment for gastroduodenal ulcer disease in patients with liver cirrhosis.
Liver cirrhosis is frequently associated with complicated peptic ulcer disease. Surgery in liver cirrhotics has a high mortality and morbidity especially when abdominal operations are performed.
Sixty-nine patients undergoing surgery for gastroduodenal ulcer disease between 1972 and 1991 were studied, retrospectively.
Ninety percent of patients required emergency surgery for bleeding ulcer (n = 45) or perforation (n = 17). Mortality was 29% for elective patients (n = 7), 35% for patients with perforation and 64% for patients with bleeding. Overall mortality of 69 patients was 54%. Only 15 of 69 patients (22%) had an uncomplicated postoperative course. Postoperative bleeding, septic complications, and renal failure were the most frequent postoperative complications. Bleeding and multiple organ failure were the leading causes of death in 70% of patients. A univariate analysis determined preoperative hemoglobin < 12 g/L (p < 0.05), systolic blood pressure < 100 mm Hg (p < 0.025), prothrombin time < 60% (p < 0.05) and the presence of portal hypertension (p < 0.01) as prognostic factors. No significant correlation with survival could be established for excretory liver function (serum bilirubin) and partial thromboplastin time.
To improve treatment results it is recommended (1) to substitute blood products (particularly coagulation factors) early and in sufficient quantities, (2) to diligently search for and to treat septic foci and administer antibiotics in a nonrestrictive manner, and (3) to restrict the operative procedure to the treatment required for control of the ulcer complication.
本研究确定了肝硬化患者胃十二指肠溃疡疾病手术治疗的危险因素。
肝硬化常与复杂性消化性溃疡疾病相关。肝硬化患者进行手术时死亡率和发病率较高,尤其是进行腹部手术时。
回顾性研究了1972年至1991年间因胃十二指肠溃疡疾病接受手术的69例患者。
90%的患者因溃疡出血(n = 45)或穿孔(n = 17)需要急诊手术。择期手术患者(n = 7)的死亡率为29%,穿孔患者为35%,出血患者为64%。69例患者的总体死亡率为54%。69例患者中只有15例(22%)术后病程顺利。术后出血、感染性并发症和肾衰竭是最常见的术后并发症。出血和多器官功能衰竭是70%患者的主要死亡原因。单因素分析确定术前血红蛋白<12 g/L(p < 0.05)、收缩压<100 mmHg(p < 0.025)、凝血酶原时间<60%(p < 0.05)和门静脉高压的存在(p < 0.01)为预后因素。排泄肝功能(血清胆红素)和部分凝血活酶时间与生存率无显著相关性。
为改善治疗效果,建议:(1)尽早足量补充血液制品(尤其是凝血因子);(2)认真查找并治疗感染灶,无限制地使用抗生素;(3)将手术操作限制在控制溃疡并发症所需的治疗范围内。